Literature DB >> 16424876

Activating mutations of JAK2V617F are uncommon in t-MDS and t-AML and are only observed in atypic cases.

F Desta, D H Christiansen, M K Andersen, J Pedersen-Bjergaard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16424876     DOI： 10.1038/sj.leu.2404072

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

Review 1.  Therapy-related myeloid leukemia.

Authors:  Lucy A Godley; Richard A Larson
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

2.  Myeloproliferative Neoplasm or Reactive Process? A Rare Case of Acute Myeloid Leukemia and Transient Posttreatment Megakaryocytic Hyperplasia with JAK-2 Mutation.

Authors:  Steven Wang; Jie Yan; Guangde Zhou; Rebecca Heintzelman; J Steve Hou
Journal:  Case Rep Hematol       Date:  2016-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.